ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer

Manish Kohli; Winston Tan; Tiantian Zheng; Amy Wang; Carlos Montesinos; Calven Wong; Pan Du; Shidong Jia; Siddhartha Yadav; Lisa G. Horvath; Kate L. Mahon; Edmond M. Kwan; Heidi Fettke; Jianjun Yu; Arun A. Azad
EBioMedicine2020-4-1DOI: 10.1016/j.ebiom.2020.102728
5阅读
引用收藏
分享

摘要

Background<br/>Metastatic prostate cancer is a clonally heterogeneous disease state characterized by progressive somatic perturbations. The aim of this study was to identify cell free DNA- (cfDNA-) based alterations and their associations with outcomes in progressive metastatic prostate cancer.<br/>Methods<br/>In this longitudinal prospective cohort study plasma cfDNA/circulating tumor DNA (ctDNA) was analyzed before, during, and after androgen deprivation therapy (ADT) in 4 independent patient groups ranging from untreated metastatic hormone sensitive prostate cancer (mHSPC) to metastatic castrate resistant prostate cancer (mCRPC). Next generation sequencing was performed on ctDNA and germline DNA to characterize alterations and associations with clinical outcomes were determined for each group.<br/>Findings<br/>cfDNA yields were different in progressive mHSPC and mCRPC states (P < .001). In mHSPC, a higher than median ctDNA fraction was predictive of shorter time to ADT failure (HR, 2.29 [95% CI, 1.13–4.65]; Log-Rank P  =  .02). cfDNA, ctDNA taken with volume of metastatic disease in mHSPC and with alkaline phosphatase levels prognosticated survival better than clinical factors alone in mHSPC and mCRPC states (Log Rank P = 0.03). ctDNA-based AR, APC mutations were increased in mCRPC compared to mHSPC (P < ·05).TP53 mutations, RB1 loss, and AR gene amplifications correlated with poorer survival in mCRPC. Mutations in multiple DNA repair genes (ATM, BRCA1, BRCA2, CHEK2) were associated with time to ADT treatment failure and survival in mHSPC.<br/>Interpretation<br/>ctDNA fraction can further refine clinical prognostic factors in metastatic prostate cancer. Somatic ctDNA alterations have potential prognostic, predictive, and therapeutic implications in metastatic prostate cancer management.<br/>Funding<br/>Several funding sources have supported this study. A full list is provided in the Acknowledgments. No funding was received from Predicine, Inc. during the conduct of the study.

学科与关键词

关键词
Circulating tumor DNAMetastatic prostate cancerGenomic alterations
相关
加载中…
  • Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
    Itsuto Hamano; Shingo Hatakeyama; Tomoko Hamaya; Kyo Togashi; Teppei Okamoto; Hayato Yamamoto; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara OhyamaIJU Case Reports, 2020, 3(4): 141-144.
  • Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis
    Zhang, Wenhui; Wang, Tao; Wang, Yan; Zhu, Feng; Shi, Haoqing; Zhang, Jili; Wang, Ziwei; Qu, Min; Zhang, Huaru; Wang, Tianyi; Qian, Yuping; Yang, Jinjian*; Gao, Xu*; Li, Jing*Translational Oncology, 2022, 16: 101311.被引 5
  • Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
    Antonarakis Emmanuel S*; Luber Brandon; Wang Hao; Isaacs William B; Luo Jun*; Antonarakis Emmanuel S; Lu Changxue; Liang Chao; Chen Yan; Silberstein John L; Piana Danilo; Isaacs William B; Luo Jun; Lai Zhao; Chen Yidong; Chen Yidong; Antonarakis ES*; Luo J*; Antonarakis ES; Luo JEuropean Urology, 2018, 74(2): 218-225.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
EBioMedicine
发表日期
2020-04-01
卷期
第 54 卷
页码
102728
DOI
10.1016/j.ebiom.2020.102728
期刊收录
NSL.SCIE
期刊等级
1区
成果收录
SCIENCEDIRECT

作者

  • M

    Manish Kohli (第一作者)

  • W

    Winston Tan

查看全部 15 位作者收起作者
  • T

    Tiantian Zheng

  • A

    Amy Wang

  • C

    Carlos Montesinos

  • C

    Calven Wong

  • P

    Pan Du

  • S

    Shidong Jia

  • S

    Siddhartha Yadav

  • L

    Lisa G. Horvath

  • K

    Kate L. Mahon

  • E

    Edmond M. Kwan

  • H

    Heidi Fettke

  • J

    Jianjun Yu

  • A

    Arun A. Azad

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417